136818-65-0 Usage
Uses
Used in Pharmaceutical Industry:
5-fluoro-6-Methoxy-1H-indole-2-carboxylic acid is utilized as a key intermediate in the synthesis of various medications, contributing to the development of treatments for a spectrum of diseases and disorders. Its unique structure allows for the creation of new drug candidates with specific therapeutic properties.
Used in Organic Synthesis:
In the realm of organic synthesis, 5-fluoro-6-Methoxy-1H-indole-2-carboxylic acid is employed as a versatile intermediate, enabling the construction of complex organic molecules for a variety of applications, including the development of new pharmaceuticals and the enhancement of existing ones.
Used in Chemical Research:
5-fluoro-6-Methoxy-1H-indole-2-carboxylic acid also plays a significant role in chemical research, where it is used to explore novel chemical reactions and mechanisms. Its presence in research settings aids in expanding the understanding of organic chemistry and the discovery of new synthetic pathways.
Overall, 5-fluoro-6-Methoxy-1H-indole-2-carboxylic acid is a multifaceted chemical with substantial implications in drug discovery and development, as well as in the broader fields of organic synthesis and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 136818-65-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,8,1 and 8 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 136818-65:
(8*1)+(7*3)+(6*6)+(5*8)+(4*1)+(3*8)+(2*6)+(1*5)=150
150 % 10 = 0
So 136818-65-0 is a valid CAS Registry Number.
136818-65-0Relevant articles and documents
QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY
-
Paragraph 0322, (2016/02/29)
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
Anti-aids piperazines
-
, (2008/06/13)
The present invention includes diaromatic substituted heterocyclic compounds (III) STR1 which are useful in treating individuals infected with the HIV virus. The invention includes certain previously generically disclosed anti-AIDS piperazinyl compounds (V) and a method of treating HIV infected individuals with the indoles of formula (V) and the anti-AIDS amines (X).
